Skip to main content

Table 4 Patient characteristics and perioperative data received lobectomy

From: Analysis of risk factors for postoperative complications in non-small cell lung cancer: comparison with the Japanese National Clinical Database risk calculator

Variables

 

Sex (man / woman)

303 / 170

Age, medial, range (y)

69 (34–92)

Comorbidity

232 (53.1%)

Malignant disease

58 (12.2%)

Hypertension

73 (15.4%)

Diabetes mellitus

71 (15.0%)

Angina pectoris

32 (6.8%)

COPD

29 (6.1%)

Cerebral infarction

20 (4.2%)

Arrhythmia

16 (3.4%)

Interstitial lung disease

7 (1.5%)

Asthma

14 (2.9%)

Autoimmune disease

11 (2.3%)

Chronic renal failure

6 (1.2%)

Body mass index, median (range)

22.9 (14.3–36.6)

CEA, median, range (ng/ml)

3.4 (0.5–269)

Brinkman index, median (range)

600 (0–3600)

PNI, median (range)

50.1 (31.8–64.2)

NLR, median (range)

2.07 (0.77–12.65)

%VC, median (range)

111.2 (45.7–184.2)

FEV1%, median (range)

73.8 (30.5–99.5)

pStage (0 / IA / IB / IIA / IIB / IIIA / IIIB / IV / yIA)

16 / 234 / 97 / 39 / 43 / 36 / 3 / 2 / 3

Histological type (Ad / Sq / LCNEC / AdSq / Pleo / Large / Carci)

362 / 81 / 14 / 8 / 2 / 3 / 3

Operative approach (Open / VATS / RATS)

48 / 419 / 6

Operative procedure

 

RUL

163 (34.5%)

RML

37 (7.8%)

RLL

94 (19.8%)

LUL

105 (22.2%)

LLL

74 (15.6%)

Morbidity

142 (30.0%)

Air leakage

67 (14.1%)

Arrhythmia

35 (7.4%)

Atelectasis

16 (3.4%)

Pneumonia

8 (1.7%)

Attack of asthma

3 (0.6%)

Cerebral infarction

3 (0.6%)

Chylothorax

2 (0.4%)

Broncho-pleural fistula

1 (0.2%)

Clavien–Dindo grade (0 / 1 / 2 / 3a / 3b)

331 / 1 / 54 / 83 / 4

Mortality

0 (0%)

Mortality or severe morbidity

52 (10.9%)

Tracheal or bronchial fistula

1 (0.2%)

Respiratory disfunction

4 (0.8%)

NCD risk score

 

Mortality, median (range) (%)

0.2 (0–10.3)

Mortality or severe morbidity, median (range) (%)

4.6 (1.2–27.3)

Tracheal or bronchial fistula, median (range) (%)

0.2 (0–3.4)

Respiratory disfunction, median (range) (%)

0.2 (0–4.4)

  1. COPD chronic obstructive pulmonary disease, CEA carcinoembryonic antigen, PNI prognostic nutritional index, NLR neutrophil-to-lymphocyte ratio, VC vital capacity, FEV1% forced expiratory volume % in one second, p pathological, y yield to treatment, Ad adenocarcinoma, Sq squamous cell carcinoma, LCNEC large cell neuroendocrine carcinoma, AdSq adenosquamous cell carcinoma, Large large cell carcinoma, Carci carcinoid, Open open thoracotomy, VATS video-assisted thoracic surgery, RATS robotic-assisted thoracic surgery RUL right upper lobectomy, RML right middle lobectomy, RLL right lower lobectomy, LUL left upper lobectomy, LLL left lower lobectomy, NCD national clinical database